TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06980025: Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

Sponsor: The George Washington University Biostatistics Center · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1800 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$15,086,080

Rescue Site Savings

+$9,947,384

Unlock Full NCT06980025 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06980025 Rescue Dossier →